NOVEL CNS-ACTIVE HEXAPEPTIDE HAVING ANTI- FORGETFULNESS ACTION
The present invention relates to hexapeptides of the general formula I R -A -A -A -A -A -A -NH(CH2)n-NH2 (I> where R denotes Z, formyl or (subst.) alkanoyl; A denotes Met, Met(O) or Met(O2), all of which can be in the L or D form; A denotes Glu, D-Glu, Ala or pyroglutamyl; A denotes His, Ala, Phe...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to hexapeptides of the general formula I R -A -A -A -A -A -A -NH(CH2)n-NH2 (I> where R denotes Z, formyl or (subst.) alkanoyl; A denotes Met, Met(O) or Met(O2), all of which can be in the L or D form; A denotes Glu, D-Glu, Ala or pyroglutamyl; A denotes His, Ala, Phe or D-Lys; A denotes the radical of a neutral aliphatic or aromatic alpha -amino acid; A denotes Lys or D-Lys; A denotes (subst.) Phe and n denotes an integer from 4 to 10. Processes for the preparation thereof, the use thereof as medicines, and pharmaceutical compositions containing these are described. |
---|